TOP TIERMARKET NEWSWIRE
News & sentiment

ARROWHEAD PHARMACEUT (ARWR) — News & AI sentiment

ARROWHEAD PHARMACEUT (ARWR) news roundup. 5 stories in the past week, 20 over 30 days. Average 30-day sentiment is 59.8/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $1.2M — net selling of $1.2M. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 1 sale (~$175K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 53/100
30d stories
20
avg sentiment 59.8/100
Insider net (90d)
$1.2M
0 buys · 2 sells
Congress (90d)
-1
0 buys · 1 sells

ARWR news in the last 24 hours, 7 days, 30 days and 90 days

How much ARWR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowARWR storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days553/100ARWR headlines →
Last 30 days2059.8/100ARWR headlines →
Last 90 days5662.3/100ARWR headlines →

Latest stories on ARWR

3d ago
4d ago
Arrowhead initiated with a Buy at Citi
The Fly61 · neutralanalyst
5d ago
7d ago
7d ago
Sep 3
Sep 2
Sep 2
Sep 1
Aug 31
Stifel reiterates Buy rating on Arrowhead Pharma stock at $104
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
RBC Capital reiterates Arrowhead Pharma stock rating on ESC data
Investing.com Analyst Ratings56 · neutralanalyst
Aug 31
Aug 30
Aug 30
Aug 30
Aug 28
Aug 27
Aug 24
Aug 17
Aug 16
Aug 6
Aug 5
Aug 5
Aug 4
Aug 4
Open ARWR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →